FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new substituted 2,3,4,5-tetra- and 2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles, their quaternary derivatives with quaternized nitrogen atom at position 2 and their salts with pharmacologically acceptable acids of the formula (I) also where R1, R2, R3 and X are given in p. 1 of the invention claim. Invention describes also methods of their synthesis and the use and pharmaceutical compositions. Indicated compounds show an anti-NMDA-activity and can be useful for treatment of patients with diseases associated with the damage of glutamateergic mediatory system: chronic neurodegenerative illnesses, for example, Alzheimer's disease, cerebral ischemia, epilepsy, schizophrenia and others. Also, invention describes a method of treatment of patients with diseases where glutamateergic mediatory system takes part as a mechanism of pathogenesis and this method of treatment involves the use of compounds of the formula (I). EFFECT: new compounds indicated above, improved method of synthesis, enhanced curative effectiveness of compounds. 46 cl, 2 tbl, 26 ex
Title | Year | Author | Number |
---|---|---|---|
REMEDY FOR IMPROVEMENT OF COGNITIVE FUNCTIONS AND MEMORY BASED ON HYDRATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL REMEDY BASED THEREON AND METHOD OF APPLICATION THEREOF | 2006 |
|
RU2334514C1 |
PHARMACEUTICAL COMPOSITION FOR NEURODEGENERATIVE DISEASES OF HYDROGENATED PYRIDO(4,3-b)INDOLE, METHOD FOR PREPARING AND BASED DRUG | 2009 |
|
RU2428185C1 |
NEW APPROACH TO TREATMENT OF ALZHEIMER'S DISEASE | 1995 |
|
RU2106864C1 |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508096C2 |
METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA WITH USING ATYPICAL NEUROLEPTIC COMBINED THERAPY | 2007 |
|
RU2508106C2 |
PHENOTHIAZINE-CONTAINING 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE DERIVATIVES AS AGENT FOR REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM, METHODS FOR PRODUCTION THEREOF, PHARMACOLOGICAL AGENT BASED THEREON AND METHOD OF REDUCING UNCONTROLLED PROTEIN AGGREGATION IN NERVOUS SYSTEM | 2013 |
|
RU2529899C1 |
DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE-CONTAINING PHENOTHIAZINES AS INHIBITORS OF CHOLINESTERASES AND BLOCKERS OF SEROTONIN RECEPTORS 5-HT, METHODS OF OBTAINING THEIR CHLOROHYDRATES AND BASED ON THEM PHARMACEUTICAL PREPARATION | 2013 |
|
RU2530881C1 |
GEROPROTECTING AGENT BASED ON HYDROGENATED PYRIDO[4,3-b]INDOLES (VARIANTS), PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD FOR ITS USING | 2003 |
|
RU2283108C2 |
LIGANDS OF ALPHA-ADRENOCEPTORS, DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND USE THEREOF | 2008 |
|
RU2407744C2 |
ADAMANTANE-CONTAINING INDOLES AND THEIR HYDROCHLORIDES WITH MICROTUBULES STABILIZING PROPERTY, METHODS OF THEIR PRODUCTION, PHARMACOLOGICAL AGENT BASED THEREON AND METHOD OF TREATING AND PREVENTING DISEASES ASSOCIATED WITH MICROTUBULE SYSTEM DISORDERS | 2015 |
|
RU2608631C1 |
Authors
Dates
1999-10-27—Published
1995-10-17—Filed